To AstraZeneca, or not to AstraZeneca: That was the question this week in Germany, when the government joined other European countries suspending its use over potentially fatal blood clotting fears. Jess Rohman, an epidemiologist and research associate at Charité's Institute of Public Health as well as the Center for Stroke Research Berlin, tells us what happened, how vaccine safety works and how we get back on track from here.
Meanwhile, Merkel reaches for the emergency brake, as COVID-19 cases surge — yet again — across Germany.
Find us on Instagram and Twitter: @Neuschlandpod. Music with thanks to Gunnar Olsen.